ACHE and Alzheimer disease: Reduced acetylcholine levels contribute to cholinergic dysfunction, a hallmark of AD, leading to impaired cholinergic neurotransmission and cognitive decline, and for these cognitive deficits, AChE inhibitors are used to increase acetylcholine levels and improve cholinergic neurotransmission temporarily [26,34].